Release Date: 23/04/20 18:03 Summary: Speedcast to recapitalise through chapter 11 Price Sensitive: Yes Download Document 165.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%